COVID Testing Kit Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932343

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932343

The global COVID Testing Kit market, which was valued at $15.08 billion in 2020, is projected to decline to $1.36 billion by 2028, reflecting a compound annual growth rate (CAGR) of -33.3% from 2021 to 2028. Despite this overall decline, the market is anticipated to experience substantial growth between 2020 and 2023. This growth can be attributed to various macro and microeconomic factors, including substantial government and private funding, as well as strong support for research and development initiatives.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Type (Rapid Test Kit, RT-PCR, Others)
By Application (Hospitals, Clinics, Others)

Key players

Abbott
BioMérieux
Bio-Rad Laboratories, Inc
Hoffmann-La Roche Ltd
Siemens
Biomedomics Inc
Zhejiang Orient Gene Biotech Co. Ltd
Cellex
Qiagen
Guangzhou Wondfo Biotech

Chapter 1. Executive Summary
Chapter 2. Scope Of The Study: 2.1. Market Definition; 2.2. Scope Of The Study; 2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends: 4.1. Supply/ Value Chain Analysis; 4.2. Porter’s Five Forces Analysis; 4.2.1. Threat Of New Entrants; 4.2.2. Bargaining Power Of Buyers; 4.2.3. Bargaining Power Of Suppliers; 4.2.4. Threat Of Substitutes; 4.2.5. Industry Rivalry; 4.3. Impact of COVID-19 on COVID Testing Kit Market; 4.3.1. Impact on Market Size; 4.3.2. End User Trend, Preferences, and Budget Impact; 4.3.3. Regulatory Framework/Government Policies; 4.3.4. Key Players Strategy to Tackle Negative Impact; 4.3.5. Opportunity Window
Chapter 5. Market Dynamics: 5.1. Introduction; 5.2. DRO Analysis; 5.2.1. Drivers; 5.2.2. Restraints; 5.2.3. Opportunities
Chapter 6. Global COVID Testing Kit Market, By Type: 6.1. Introduction; 6.2. Rapid Test Kit; 6.3. RT-PCR; 6.3. Others
Chapter 7. Global COVID Testing Kit Market, By Application: 7.1. Introduction; 7.2. Hospitals; 7.3. Clinics; 7.4. Others
Chapter 8. Global COVID Testing Kit Market, By Region: 8.1. Introduction; 8.2. North America; 8.2.1. Introduction; 8.2.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.3. Market Size and Forecast, By Country, 2020 - 2028; 8.2.4. Market Size and Forecast, By Type, 2020 - 2028; 8.2.5. Market Size and Forecast, By Application, 2020 – 2028; 8.2.6. US; 8.2.6.1. Introduction; 8.2.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.6.3. Market Size and Forecast, By Type, 2020 - 2028; 8.2.6.4. Market Size and Forecast, By Application, 2020 - 2028; 8.2.7. Canada; 8.2.7.1. Introduction; 8.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.7.3. Market Size and Forecast, By Type, 2020 - 2028; 8.2.7.4. Market Size and Forecast, By Application, 2020 - 2028; 8.3. Europe; 8.3.1. Introduction; 8.3.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.3. Market Size and Forecast, By Country, 2020 - 2028; 8.3.4. Market Size and Forecast, By Type, 2020 - 2028; 8.3.5. Market Size and Forecast, By Application, 2020 – 2028; 8.3.6. Germany; 8.3.6.1. Introduction; 8.3.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.6.3. Market Size and Forecast, By Type, 2020 - 2028; 8.3.6.4. Market Size and Forecast, By Application, 2020 - 2028; 8.3.7. France; 8.3.7.1. Introduction; 8.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.7.3. Market Size and Forecast, By Type, 2020 - 2028; 8.3.7.4. Market Size and Forecast, By Application, 2020 - 2028; 8.3.8. UK; 8.3.8.1. Introduction; 8.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.8.3. Market Size and Forecast, By Type, 2020 - 2028; 8.3.8.4. Market Size and Forecast, By Application, 2020 - 2028; 8.3.9. Italy; 8.3.9.1. Introduction; 8.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.9.3. Market Size and Forecast, By Type, 2020 - 2028; 8.3.9.4. Market Size and Forecast, By Application, 2020 - 2028; 8.3.10. Rest Of Europe; 8.3.10.1. Introduction; 8.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.10.3. Market Size and Forecast, By Type, 2020 - 2028; 8.3.10.4. Market Size and Forecast, By Application, 2020 - 2028; 8.4. Asia-Pacific; 8.4.1. Introduction; 8.4.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.3. Market Size and Forecast, By Country, 2020 - 2028; 8.4.4. Market Size and Forecast, By Type, 2020 - 2028; 8.4.5. Market Size and Forecast, By Application, 2020 - 2028; 8.4.6. China; 8.4.6.1. Introduction; 8.4.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.6.3. Market Size and Forecast, By Type, 2020 - 2028; 8.4.6.4. Market Size and Forecast, By Application, 2020 - 2028; 8.4.7. India; 8.4.7.1. Introduction; 8.4.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.7.3. Market Size and Forecast, By Type, 2020 - 2028; 8.4.7.4. Market Size and Forecast, By Application, 2020 - 2028; 8.4.8. Japan; 8.4.8.1. Introduction; 8.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.8.3. Market Size and Forecast, By Type, 2020 - 2028; 8.4.8.4. Market Size and Forecast, By Application, 2020 - 2028; 8.4.9. South Korea; 8.4.9.1. Introduction; 8.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.9.3. Market Size and Forecast, By Type, 2020 - 2028; 8.4.9.4. Market Size and Forecast, By Application, 2020 - 2028; 8.4.10. Rest Of Asia-Pacific; 8.4.10.1. Introduction; 8.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.10.3. Market Size and Forecast, By Type, 2020 - 2028; 8.4.10.4. Market Size and Forecast, By Application, 2020 - 2028; 8.5. Rest Of The World (RoW); 8.5.1. Introduction; 8.5.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.3. Market Size and Forecast, By Type, 2020 - 2028; 8.5.4. Market Size and Forecast, By Application, 2020 - 2028; 8.5.5. Market Size and Forecast, By Region, 2020 - 2028; 8.5.6. South America; 8.5.6.1. Introduction; 8.5.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.6.3. Market Size and Forecast, By Type, 2020 - 2028; 8.5.6.4. Market Size and Forecast, By Application, 2020 - 2028; 8.5.7. Middle East and Africa; 8.5.7.1. Introduction; 8.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.7.3. Market Size and Forecast, By Type, 2020 - 2028; 8.5.7.4. Market Size and Forecast, By Application, 2020 - 2028
Chapter 9. Competitive Landscape: 9.1. Introduction; 9.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 10. Company Profiles: 10.1. Abbott; 10.1.1. Business Overview; 10.1.2. Financial Analysis; 10.1.3. Product Portfolio; 10.1.4. Recent Development and Strategies Adopted; 10.1.5. SWOT Analysis; 10.2. BioMérieux; 10.2.1. Business Overview; 10.2.2. Financial Analysis; 10.2.3. Product Portfolio; 10.2.4. Recent Development and Strategies Adopted; 10.2.5. SWOT Analysis; 10.3. Bio-Rad Laboratories, Inc; 10.3.1. Business Overview; 10.3.2. Financial Analysis; 10.3.3. Product Portfolio; 10.3.4. Recent Development and Strategies Adopted; 10.3.5. SWOT Analysis; 10.4. F. Hoffmann-La Roche Ltd; 10.4.1. Business Overview; 10.4.2. Financial Analysis; 10.4.3. Product Portfolio; 10.4.4. Recent Development and Strategies Adopted; 10.4.5. SWOT Analysis; 10.5. Siemens; 10.5.1. Business Overview; 10.5.2. Financial Analysis; 10.5.3. Product Portfolio; 10.5.4. Recent Development and Strategies Adopted; 10.5.5. SWOT Analysis; 10.6. Biomedomics Inc; 10.6.1. Business Overview; 10.6.2. Financial Analysis; 10.6.3. Product Portfolio; 10.6.4. Recent Development and Strategies Adopted; 10.6.5. SWOT Analysis; 10.7. Zhejiang Orient Gene Biotech Co. Ltd; 10.7.1. Business Overview; 10.7.2. Financial Analysis; 10.7.3. Product Portfolio; 10.7.4. Recent Development and Strategies Adopted; 10.7.5. SWOT Analysis; 10.8. Cellex; 10.8.1. Business Overview; 10.8.2. Financial Analysis; 10.8.3. Product Portfolio; 10.8.4. Recent Development and Strategies Adopted; 10.8.5. SWOT Analysis; 10.9. Qiagen; 10.9.1. Business Overview; 10.9.2. Financial Analysis; 10.9.3. Product Portfolio; 10.9.4. Recent Development and Strategies Adopted; 10.9.5. SWOT Analysis; 10.10. Guangzhou Wondfo Biotech; 10.10.1. Business Overview; 10.10.2. Financial Analysis; 10.10.3. Product Portfolio; 10.10.4. Recent Development and Strategies Adopted; 10.10.5. SWOT Analysis
Chapter 11. Key Takeaways